Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Advanced Biliary Tract Cancer × tislelizumab × Clear all

Phase

Status

Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 14 Colorectal Neoplasms 7 Stomach Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Cholangiocarcinoma 4 Uterine Cervical Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Rectal Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Lymphoma, Extranodal NK-T-Cell 2 Liver Neoplasms 2 Carcinoma, Transitional Cell 2 Breast Neoplasms 2 Urothelial Carcinoma Bladder 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Diseases 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Potentially Resectable Locally Advanced Malignant Tumors of Biliary System 1 Patients With Advanced Metastatic Colorectal Cancer 1 PD-1 Antibody 1

Interventions

lenvatinib 3 sintilimab 2 tislelizumab 1 theasinensin A 1 S 1 (combination) 1 Gemcitabine 1 Cryosurgery 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05823987 2023-06-27

OPTIONS-05

Fudan University

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡